{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:02:33Z","timestamp":1789952553503,"version":"4.0.1"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0899823X25102596_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To describe trends in the prevalence of healthcare-associated infections (HAIs) and antibiotic-resistant organisms (AROs) in Canadian acute-care hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25102596_as2\">\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Repeated point prevalence surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25102596_as3\">\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25102596_as4\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Trained infection control professionals reviewed medical records of eligible adult patients and applied standardized definitions to collect demographic data and information on HAIs, AROs, and additional precautions from 39 to 62 hospitals in 2002, 2009, 2017, and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25102596_as5\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of adult patients with at least one HAI increased from 10.4% (95% CI: 9.6%\u201311.2%) in 2002 to 12.4% (95% CI: 11.7%\u201313.2%) in 2009, declined to 8.4% (95% CI: 7.8%\u20139.0%) in 2017, and stabilized in 2024 (8.1%, 95% CI: 7.6%\u20138.6%) despite 3.1% of HAIs being due to SARS-CoV-2. Between 2017 and 2024, there were increases in bloodstream infections (1.0% to 1.5%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002), viral respiratory infections (VRI) (0.3% to 0.6%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), and in the prevalence of patients on additional precautions for carbapenemase-producing organisms (0.1% to 1.7%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001) and VRIs (2.1% to 3.6%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). In 2024, AROs were responsible for 6.6% of infections. One-third of HAIs were device-associated, and the prevalence of central line-associated bloodstream infections (CLABSIs) doubled from 0.4% in 2017 to 0.7% in 2024,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.02.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25102596_as6\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A point prevalence survey performed in Canada in 2024 following the COVID-19 pandemic identified a stable prevalence of HAIs and AROs despite the inclusion of SARS-CoV-2. Concerning trends were observed including the increased prevalence of certain HAIs such as CLABSIs and VRIs highlighting the need for ongoing efforts in hospital infection prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ice.2025.10259","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:04:25Z","timestamp":1757505865000},"page":"984-991","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Trends in healthcare-associated infections and antimicrobial-resistant organisms among adults in Canadian acute care hospitals: findings from four point prevalence surveys, 2002 to 2024"],"prefix":"10.1017","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-196X","authenticated-orcid":false,"given":"Robyn","family":"Mitchell","sequence":"first","affiliation":[{"name":"Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4660-2109","authenticated-orcid":false,"given":"Diane","family":"Lee","sequence":"additional","affiliation":[{"name":"Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-3538","authenticated-orcid":false,"given":"Jessica","family":"Bartoszko","sequence":"additional","affiliation":[{"name":"Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5792-4246","authenticated-orcid":false,"given":"Cassandra","family":"Lybeck","sequence":"additional","affiliation":[{"name":"Canadian Nosocomial Infection Surveillance Program, Public Health Agency of Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve","family":"Benoit","sequence":"additional","affiliation":[{"name":"CHU Sainte-Justine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-674X","authenticated-orcid":false,"given":"Jeannette","family":"Comeau","sequence":"additional","affiliation":[{"name":"Dalhousie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-9519","authenticated-orcid":false,"given":"Jennifer","family":"Ellison","sequence":"additional","affiliation":[{"name":"Alberta Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-0766","authenticated-orcid":false,"given":"Charles","family":"Frenette","sequence":"additional","affiliation":[{"name":"McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5407-6552","authenticated-orcid":false,"given":"Jennifer","family":"Happe","sequence":"additional","affiliation":[{"name":"Alberta Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Haslam","sequence":"additional","affiliation":[{"name":"Health Sciences North"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonita","family":"Lee","sequence":"additional","affiliation":[{"name":"Stollery Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-1613","authenticated-orcid":false,"given":"Dominik","family":"Mertz","sequence":"additional","affiliation":[{"name":"Hamilton Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-0083","authenticated-orcid":false,"given":"Stephanie W.","family":"Smith","sequence":"additional","affiliation":[{"name":"University of Alberta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-2186","authenticated-orcid":false,"given":"Daniel","family":"Thirion","sequence":"additional","affiliation":[{"name":"McGill University Health Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5760-0136","authenticated-orcid":false,"given":"Alice","family":"Wong","sequence":"additional","affiliation":[{"name":"Royal University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2855-8570","authenticated-orcid":false,"given":"Michelle","family":"Science","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-7033","authenticated-orcid":false,"given":"Susy","family":"Hota","sequence":"additional","affiliation":[{"name":"University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"S0899823X25102596_ref13","unstructured":"13. Canadian Nosocomial Infection Surveillance Program. CNISP Acute Care Point Prevalence Survey Protocol. Ottawa: PHAC; 2024. https:\/\/ipac-canada.org\/photos\/custom\/Members\/CNISPpublications\/2024_CNISP_PPS%20protocol_EN_V1.5.pdf"},{"key":"S0899823X25102596_ref20","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.390"},{"key":"S0899823X25102596_ref3","doi-asserted-by":"publisher","DOI":"10.1086\/598328"},{"key":"S0899823X25102596_ref26","article-title":"Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024","author":"Tan","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0899823X25102596_ref34","volume-title":"Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level","year":"2016"},{"key":"S0899823X25102596_ref4","volume-title":"Point-Prevalence Survey of Healthcare-Associated Infections and Antimicrobial use in European Acute-Care Hospitals 2011\u20132012","year":"2013"},{"key":"S0899823X25102596_ref11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190361"},{"key":"S0899823X25102596_ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0904"},{"key":"S0899823X25102596_ref7","volume-title":"\u00c5rsrapport 2017 \u2013 Infeksjoner og antibiotikabruk i helseinstitusjoner i Norge","author":"Espenhain","year":"2018"},{"key":"S0899823X25102596_ref29","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.88"},{"key":"S0899823X25102596_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30605-4"},{"key":"S0899823X25102596_ref23","volume-title":"Point-Prevalence Survey of Healthcare-Associated Infections and Antimicrobial use in European Acute Care Hospitals \u2013 2022\u20132023","year":"2024"},{"key":"S0899823X25102596_ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-025-01602-w"},{"key":"S0899823X25102596_ref10","first-page":"78","volume-title":"Bennett and Brachman\u2019s Hospital Infections","author":"Magill","year":"2023"},{"key":"S0899823X25102596_ref16","unstructured":"16. Canadian Nosocomial Infection Surveillance Program. Surveillance Protocol for Viral Respiratory Infections. Ottawa: PHAC; 2024. https:\/\/ipac-canada.org\/photos\/custom\/Members\/CNISPpublications\/CNISP%202024%20VRI%20Protocol_EN.pdf"},{"key":"S0899823X25102596_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2022.10.002"},{"key":"S0899823X25102596_ref12","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190948"},{"key":"S0899823X25102596_ref18","unstructured":"18. Canadian Nosocomial Infection Surveillance Program. Point Prevalence Survey Validation Protocol. Ottawa: PHAC; 2024. https:\/\/ipac-Canada.org\/photos\/custom\/Members\/CNISPpublications\/2024_CNISP_PPS_validation%20protocol_EN_V1.3.pdf"},{"key":"S0899823X25102596_ref21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091258"},{"key":"S0899823X25102596_ref19","volume-title":"R: A Language and Environment for Statistical Computing","author":"Core Team","year":"2023"},{"key":"S0899823X25102596_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"S0899823X25102596_ref17","unstructured":"17. Canadian Nosocomial Infection Surveillance Program. Surveillance Protocol for Central Line Associated Bloodstream Infections in Intensive Care Units. Ottawa: PHAC; 2024. https:\/\/ipac-canada.org\/photos\/custom\/Members\/CNISPpublications\/CNISP%202024%20CLABSI%20Protocol_EN_final.pdf"},{"key":"S0899823X25102596_ref28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13020123"},{"key":"S0899823X25102596_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2023.07.025"},{"key":"S0899823X25102596_ref15","unstructured":"15. National Healthcare Safety Network. CDC\/NHSN Surveillance Definitions for Specific Types of Infections. January 2023. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf"},{"key":"S0899823X25102596_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107837"},{"key":"S0899823X25102596_ref31","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.87"},{"key":"S0899823X25102596_ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801550"},{"key":"S0899823X25102596_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.12.004"},{"key":"S0899823X25102596_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0570-y"},{"key":"S0899823X25102596_ref24","volume-title":"English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2022 to 2023","year":"2023"},{"key":"S0899823X25102596_ref14","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v48i1112a03"},{"key":"S0899823X25102596_ref5","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516"},{"key":"S0899823X25102596_ref32","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.304"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X25102596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:52:06Z","timestamp":1789951926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X25102596\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0899823X25102596"],"URL":"https:\/\/doi.org\/10.1017\/ice.2025.10259","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}